Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Pescara
Clinical trial register · Italy

Clinical Trials in Pescara, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Pescara

25 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
50
Pescara, Torino
2026-07-15
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
41
Alessandria, Bologna, Brescia, Florence, Genova, Milan, Palermo, Pescara
2026-06-05
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Bari, Bologna, Bolzano, Milan, Novara, Palermo, Pescara, Rimini
2026-05-31
By invitation
Novo Nordisk A/S
Observational
214
Pescara, San Giovanni in Fiore (CS), Marano Di Napoli (NA), Rome, Milan, Cuneo, Catania, Bolzano
2026-05-28
Not yet open
Antonio Pierini
Phase 2
28
Perugia, Pescara
2026-04
Active, closed
Janssen Research & Development, LLC
Phase 2
168
Bergamo, Bologna, Cuneo, Florence, Palermo, Pavia, Pescara, Roma
2026-02-08
Recruiting
Takeda
Phase 3
183
Catania, Pavia, Pescara, Roma, Torrette
2026-01-14
Recruiting
Takeda
Phase 3
70
Messina, Milan, Pescara, Roma
2025-10-27
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Ancona, Bologna, Civitanova Marche, Milan, Pagani, Palermo, Perugia, Pescara
2025-05-05
Active, closed
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Not applicable
110
Brescia, Isernia, Milan, Pescara
2025-05-01
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
47
Alessandria, Pescara, Ancona, Avellino, Aviano, Brescia, Florence, Milan
2025-04-09
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 3
339
Bologna, Genova, Palermo, Pescara, Perugia, Ravenna, Roma, Torino
2025-02-27
By invitation
Learning Curves of Different Devices for Vaginal Birth on Mannequin
NCT06923319Forceps Delivery Affecting Fetus or Newborn, Ventouse Extraction;Liveborn, Birth; Forced
G. d'Annunzio University
Observational
30
Chieti, Pescara
2025-02-01
Recruiting
Takeda
Phase 3
70
Messina, Milan, Pescara, Rome
2025-01-22
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Ancona, Bergamo, Brescia, Genova, Milan, Pescara, Perugia, Pisa
2024-10-29
Recruiting
Prevention ICONA Dedicated Ensemble
NCT07186244PrEP, PrEP Adherence Monitoring, HIV, HIV -1 Infection
Fondazione ICONA
Observational
5,000
Chieti, Pescara, Bari, Foggia, Potenza, Caserta, Naples, Bologna
2024-09-09
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Alessandria, Ancona, Genova, Milan, Rozzano, Pescara, Pisa, Pavia
2024-09-04
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Bergamo, Bologna, Florence, Pescara, Roma, San Giovanni Rotondo, Trieste
2024-01-19
Recruiting
Translumina Therapeutics Pvt Ltd.
Observational
2,000
Campobasso, Mercogliano AV, Naples, Padova, Pescara, Roma
2024-01-10
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Observational
496
Alessandria, Ponderano, Cagliari, Catania, Milan, Palermo, Padova, Pescara
2020-12-01
Active, closed
Karyopharm Therapeutics Inc
Phase 2/3
501
Ancona, Caserta, Naples, Novara, Pescara, Rome, Palermo, Turin
2020-09-03
Active, closed
Pyruvate Kinase Deficiency Global Longitudinal Registry
NCT03481738Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc.
Observational
500
Pescara, Naples, Genoa, Milan, Roma
2018-04-23
Recruiting
Two Previous Cesarean and Vaginal Birth Before and After Starting Training and Protocols
NCT07258459Cesarean Delivery Affecting Fetus or Newborn, Labor (Obstetrics)--Complications, Hemorrhagic Complications
G. d'Annunzio University
Observational
2,016
Pescara
2016-01-01
Active, closed
AbbVie
Observational
1,446
Milan, Rome, Bologna, Messina, Naples, Palermo, Parma, Pescara
2014-08-28
Active, closed
Italfarmaco
Phase 2
90
Bari, Bergamo, Florence, Milan, Pescara, Pavia, Reggio Calabria, Vicenza
2013-03
Rows per page Showing 1–25 of 25
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/pescara

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 25 of those studies with a site in Pescara.

How many clinical trials are recruiting in Pescara?

11 of the 25 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 10 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Pescara), 25 studies
PhaseStudiesRecruitingShare
Observational9336%
Phase 27228%
Phase 37628%
Not applicable104%
Phase 2/3104%

Most active sponsors

Lead sponsors with the most studies (Pescara)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC31
Takeda33
Fondazione Italiana Linfomi - ETS22
G. d'Annunzio University21
Novartis Pharmaceuticals20
AbbVie10
Agios Pharmaceuticals, Inc.10
Antonio Pierini10
Fondazione ICONA11
Fondazione Policlinico Universitario Agostino Gemelli IRCCS10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.